186 related articles for article (PubMed ID: 24860987)
1. Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women-2 years of screening experience from Denmark.
Clausen FB; Steffensen R; Christiansen M; Rudby M; Jakobsen MA; Jakobsen TR; Krog GR; Madsen RD; Nielsen KR; Rieneck K; Sprogøe U; Homburg KM; Baech J; Dziegiel MH; Grunnet N
Prenat Diagn; 2014 Oct; 34(10):1000-5. PubMed ID: 24860987
[TBL] [Abstract][Full Text] [Related]
2. Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis.
Clausen FB; Christiansen M; Steffensen R; Jørgensen S; Nielsen C; Jakobsen MA; Madsen RD; Jensen K; Krog GR; Rieneck K; Sprogøe U; Homburg KM; Grunnet N; Dziegiel MH
Transfusion; 2012 Apr; 52(4):752-8. PubMed ID: 21995641
[TBL] [Abstract][Full Text] [Related]
3. Determination of fetal RHD type in plasma of RhD negative pregnant women.
Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA
Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532
[TBL] [Abstract][Full Text] [Related]
4. Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland.
Haimila K; Sulin K; Kuosmanen M; Sareneva I; Korhonen A; Natunen S; Tuimala J; Sainio S
Acta Obstet Gynecol Scand; 2017 Oct; 96(10):1228-1233. PubMed ID: 28718198
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma.
Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Kulovany E; Vlk R
Fetal Diagn Ther; 2005; 20(4):275-80. PubMed ID: 15980640
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of multiplex real-time PCR assay for noninvasive prenatal assessment of fetal RhD status and fetal sex in maternal plasma.
Ordoñez E; Rueda L; Cañadas MP; Fuster C; Cirigliano V
Fetal Diagn Ther; 2013; 34(1):13-8. PubMed ID: 23548569
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive fetal RhD status determination in early pregnancy.
Manzanares S; Entrala C; Sánchez-Gila M; Fernández-Rosado F; Cobo D; Martinez E; Molina L; Reche R; Pineda A; Gallo JL
Fetal Diagn Ther; 2014; 35(1):7-12. PubMed ID: 24335165
[TBL] [Abstract][Full Text] [Related]
8. Prenatal screening service for fetal RHD genotyping to guide prophylaxis: the two-year experience of the Friuli Venezia Giulia region in Italy.
Londero D; Merluzzi S; Dreossi C; Barillari G
Blood Transfus; 2023 Mar; 21(2):93-99. PubMed ID: 35848630
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive fetal RhD genotyping.
Clausen FB; Damkjær MB; Dziegiel MH
Transfus Apher Sci; 2014 Apr; 50(2):154-62. PubMed ID: 24642067
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive fetal RHD genotyping by maternal plasma with capillary electrophoresis.
Kimura M; Sato C; Hara M; Ishihara O; Ikebuchi K
Transfusion; 2008 Jun; 48(6):1156-63. PubMed ID: 18422850
[TBL] [Abstract][Full Text] [Related]
11. Analysis of false-positive results of fetal RHD typing in a national screening program reveals vanishing twins as potential cause for discrepancy.
Thurik FF; Ait Soussan A; Bossers B; Woortmeijer H; Veldhuisen B; Page-Christiaens GC; de Haas M; van der Schoot CE
Prenat Diagn; 2015 Aug; 35(8):754-60. PubMed ID: 25855535
[TBL] [Abstract][Full Text] [Related]
12. Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women.
Clausen FB; Krog GR; Rieneck K; Nielsen LK; Lundquist R; Finning K; Dickmeiss E; Hedegaard M; Dziegiel MH
Prenat Diagn; 2005 Nov; 25(11):1040-4. PubMed ID: 16231312
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive fetal RHD genotyping in the first trimester of pregnancy.
Cardo L; García BP; Alvarez FV
Clin Chem Lab Med; 2010 Aug; 48(8):1121-6. PubMed ID: 20482298
[TBL] [Abstract][Full Text] [Related]
14. Antenatal
Clausen FB
Immunohematology; 2024 Apr; 40(1):15-27. PubMed ID: 38739027
[TBL] [Abstract][Full Text] [Related]
15. Costs and benefits of non-invasive fetal RhD determination.
Teitelbaum L; Metcalfe A; Clarke G; Parboosingh JS; Wilson RD; Johnson JM
Ultrasound Obstet Gynecol; 2015 Jan; 45(1):84-8. PubMed ID: 25380024
[TBL] [Abstract][Full Text] [Related]
16. RHD genotyping from maternal plasma: guidelines and technical challenges.
Avent ND
Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
[TBL] [Abstract][Full Text] [Related]
17. High-throughput non-invasive prenatal testing for fetal rhesus D status in RhD-negative women not known to be sensitised to the RhD antigen: a systematic review and economic evaluation.
Saramago P; Yang H; Llewellyn A; Walker R; Harden M; Palmer S; Griffin S; Simmonds M
Health Technol Assess; 2018 Mar; 22(13):1-172. PubMed ID: 29580376
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive Antenatal Screening for Fetal RHD in RhD Negative Women to Guide Targeted Anti-D Prophylaxis.
Clausen FB; Rieneck K; Krog GR; Bundgaard BS; Dziegiel MH
Methods Mol Biol; 2019; 1885():347-359. PubMed ID: 30506209
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands.
de Haas M; Thurik FF; van der Ploeg CP; Veldhuisen B; Hirschberg H; Soussan AA; Woortmeijer H; Abbink F; Page-Christiaens GC; Scheffer PG; Ellen van der Schoot C
BMJ; 2016 Nov; 355():i5789. PubMed ID: 27821701
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive fetal RHD genotyping from maternal plasma in an admixed Brazilian population.
Schmidt LC; Cabral AC; Faria MA; Monken F; Tarazona-Santos E; Martins ML
Genet Mol Res; 2014 Feb; 13(1):799-805. PubMed ID: 24615044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
